Sign Up Today and Learn More About ResearchGate Stock
Invest in or calculate the value of your shares in ResearchGate or other pre-IPO companies through EquityZen's platform.
About ResearchGate Stock
Founded
2008
Industries
Professional Services, Community and Lifestyle, Media and Entertainment
ResearchGate is the professional network for scientists. Researchers use it to connect, collaborate, share results and drive progress. ResearchGate is a professional network for scientists and researchers. It started when two researchers discovered first-hand that collaborating with a friend or colleague on the other side of the world was no easy task. Founded in 2008 by physicians Dr. Ijad Madisch and Dr. Sören Hofmayer, and computer scientist Horst Fickenscher, ResearchGate today has more than 14 million members. ResearchGate's international team of 300 people is based in the vibrant start-up capital Berlin. ResearchGate's mission is to connect the world of science and make research open to all.
ResearchGate Press Mentions
Stay in the know about the latest news on ResearchGate
5 Interesting Startup Deals You May Have Missed In September: Seedless Fruit, Better Pet Care And A Lot More
news • Sep 26, 2024
ResearchGate Newsroom | New partnership between ResearchGate and Pensoft to drive readership and visibility of ...
researchgate • May 05, 2024
ResearchGate and Taylor & Francis Partner to Help Researchers Discover Journals
labmanager • Feb 20, 2024
ResearchGate and Emerald partner to drive journal readership
researchinformation • Feb 11, 2024
Academic Publishing: ResearchGate Expands Sage Journals
publishingperspectives • Feb 11, 2024
Investors in ResearchGate
Discover investors in ResearchGate stock and explore their portfolio companies
ResearchGate Management
Leadership team at ResearchGate
Chief Executive Officer
Ijad Madisch
Join now and verify your accreditation status to gain access to:
- ResearchGate current valuation
- ResearchGate stock price
- Available deals in ResearchGate and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in ResearchGate stock?
Accredited investors can buy pre-IPO stock in companies like ResearchGate through EquityZen funds. These investments are made available by existing ResearchGate shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ResearchGate stock?
Shareholders can sell their ResearchGate stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
